Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients.

Danilo Candido de AlmeidaMaria do Carmo Pinho FrancoDavi Rettori Pardo Dos SantosMarina Colella SantosIsabela Soucin MaltoniFelipe MascotteAlexandra Aparecida de SouzaPaula Massaroni PietrobomEduardo Alexandrino MedeirosPaulo Roberto Abrão FerreiraFlavia Ribeiro MachadoMiguel Ângelo Goes

Published in: PloS one (2021)

In our study, the development of AKI in patients with severe COVID-19 was related to inflammatory blood markers and therapy with hydroxychloroquine/azithromycin, with vasopressor requirement and hypertension considered potential risk factors. Thus, attention to the protocol, hypertension, and some blood markers may help assist doctors with decision-making for the management of COVID-19 patients with AKI.

Keyphrases

risk factors
acute kidney injury
sars cov
coronavirus disease
blood pressure
cardiac surgery
decision making
early onset
randomized controlled trial
respiratory syndrome coronavirus
working memory
oxidative stress
type diabetes
risk assessment
stem cells
skeletal muscle
smoking cessation
bone marrow